Zydus Lifesciences gets final FDA approval for Mirabegron generic

Pallavi Madhiraju- October 4, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More

Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug

Pallavi Madhiraju- October 2, 2022 0

Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the ... Read More

Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

pallavi123- September 20, 2022 0

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

pallavi123- September 18, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

FDA makes four Form 483 observations at Zydus Lifesciences facility

pallavi123- August 7, 2022 0

Zydus Lifesciences (formerly known as Cadila Healthcare) said that the US Food and Drug Administration (FDA) completed an inspection of its Moraiya manufacturing plant in ... Read More

Zydus Lifesciences gets FDA approval for Ivermectin Cream, 1%

pallavi123- August 4, 2022 0

Zydus Lifesciences (previously called Cadila Healthcare) has secured final approval for antiparasitic ointment Ivermectin Cream, 1% from the US Food and Drug Administration (FDA). Ivermectin ... Read More

Zydus Lifesciences launches diabetes drugs Sitaglyn and Siglyn in India

pallavi123- July 10, 2022 0

Zydus Lifesciences (Cadila Healthcare) has rolled out the molecule Sitagliptin in India under the Sitaglyn and Siglyn brand names for the treatment of Type 2 ... Read More

Zydus Lifesciences gets FDA approval for Adapalene and Benzoyl Peroxide Topical Gel

pallavi123- June 7, 2022 0

Zydus Lifesciences (previously Cadila Healthcare) said that it has secured final approval from the US Food and Drug Administration (FDA) for marketing Adapalene and Benzoyl ... Read More

Zydus Lifesciences gets FDA approval for Bortezomib for Injection

pallavi123- May 3, 2022 0

Zydus Lifesciences (previously called Cadila Healthcare) said that it has secured final approval from the US Food and Drug Administration (FDA) to market Bortezomib for ... Read More